Proof of Usefulness Report

Parallel Bio

Analysis completed on 2/4/2026

+613
Proof of Usefulness Score
Category Standard

Parallel Bio is a legitimate, high-potential Series A biotechnology company (approx. $30M in funding, backed by Y Combinator and AIX Ventures) developing immune organoid platforms to replace animal testing. However, the submission itself ('DeepBlade') contains demonstrably false claims (e.g., 'most people have used my product') and low-quality data. The score reflects the verified high value and strong market traction of the actual company, significantly penalized for the lack of integrity in the submission response.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+237.5
Audience Reach Impact+50.0
Technical Innovation+165.6
Evidence Of Traction+100.0
Market Timing Relevance+90.0
Functional Completeness+2.5
Subtotal+645.6
Usefulness Multiplierx0.95
Final Score+613

Project Details

Project URL
parallel.bio
Description
Parallel Bio is a biotechnology company focused on revolutionizing drug discovery and development. They utilize a proprietary platform that replicates the human immune system in a dish using immune organoids and AI. This approach aims to create more accurate models of human biology, leading to safer, faster, and more efficient development of immunotherapies and other drugs, ultimately reducing the high failure rates in traditional clinical trials.

Algorithm Insights

Market Position
Strong market validation with clear user adoption patterns
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline